The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 09, 2021
Filed:
Mar. 03, 2020
Applicant:
Fujifilm Corporation, Tokyo, JP;
Inventors:
Tsukasa Kitahashi, Ashigarakami-gun, JP;
Shinji Mima, Ashigarakami-gun, JP;
Takeshi Matsumoto, Ashigarakami-gun, JP;
Takahiro Sekiguchi, Ashigarakami-gun, JP;
Mikinaga Mori, Ashigarakami-gun, JP;
Assignee:
FUJIFILM Corporation, Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61K 31/337 (2006.01); A61K 31/7068 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/127 (2013.01); A61K 31/337 (2013.01); A61K 31/7068 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61P 35/00 (2018.01);
Abstract
An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.